RemSleep Holdings (RMSL) Enterprise Value Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13.43% |
| Sep 30, 2025 | -28.85% |
| Jun 30, 2025 | -54.18% |
| Mar 31, 2025 | -15.34% |
| Dec 31, 2024 | -31.62% |
| Sep 30, 2024 | -39.37% |
| Jun 30, 2024 | -30.91% |
| Mar 31, 2024 | -75.13% |
| Dec 31, 2023 | -112.39% |
| Sep 30, 2023 | -85.70% |
| Jun 30, 2023 | -355.32% |
| Mar 31, 2023 | -94.77% |
| Dec 31, 2022 | -291.06% |
| Sep 30, 2022 | -729.58% |
| Dec 31, 2020 | -302.60% |
| Mar 31, 2019 | -208.78% |
| Sep 30, 2018 | -736.50% |
| Jun 30, 2018 | -28.47% |
| Mar 31, 2018 | -136.93% |
| Dec 31, 2017 | -33.33% |
| Sep 30, 2017 | 68.85% |
| Dec 31, 2015 | 60.15% |